New Delhi: Indian vaccine maker 'Bharat Biotech' is going to reduce the production of the anti-corona vaccine Covaxin for some time. The vaccine manufacturing company said it is temporarily reducing the production of corona vaccine Covaxin in all its production units. The company says that the procurement agencies have already met the supply obligations and the demand is expected to be deficient. In this situation, it has been decided to reduce production.

The company further said that the process of further improving and upgrading the vaccine is being worked out after a recent inspection by the World Health Organization (WHO) in view of the emergency use of the vaccine. This will ensure that The Vaccine continues to meet the changing global regulatory needs over time.

Bharat Biotech said in a statement that for the coming period the company will focus on maintenance, process and facility optimization activities. The company said all the existing units were repurposed for the manufacture of Covaxin for continuous production of the vaccine during the last one year. Therefore, in view of all these aspects, it is necessary to work to upgrade the facilities.

India is working tirelessly to beat England

Covid Roundup: India logs 1260 new cases, 83 fatalities in 24-hrs

Mata Vaishno Devi Temple decorated, long queues of devotees for darshan